MOBILE PHARMACY BUSINESS PLAN
Â
I. Executive Summary
Company Description
PulseDrop Mobile Pharmacy — named to convey fast, discreet delivery tied to personal health — is a 2026 U.S. launch in the mobile health sector. We operate a full-service, on-demand prescription and essentials delivery service that connects patients with licensed pharmacists through a proprietary, HIPAA-compliant app. Core offerings include same-day prescription delivery, pharmacist video consultations, automated refill management, and discreet packaging. One-liner: fast, private pharmacy service that replaces an in-person retail trip.
We run a lean fixed-cost base (centralized pharmacy hub, small admin team) and a scalable variable-cost delivery fleet. Key activities: pharmacist dispensing, telepharmacy consultations, route-optimized same-day logistics, and app-driven adherence programs. We target urban adults with chronic conditions, gig workers, and privacy-conscious patients in major metropolitan areas. Short-term goal: launch in Q2 2026 and reach 10,000 active users with 3,000 monthly orders in year one. Long-term goal: expand to 10 U.S. metros and 200,000 active users by 2029. One-liner: scalable urban rollout with measurable user and metro expansion targets.
Â
Problem
Long pharmacy trips, missed pickups, and fragmented digital tools create barriers to timely medication access for older adults, people with mobility limits, busy professionals, parents, and caregivers. These gaps increase missed doses, raise travel time and costs, and multiply caregiver administrative work.
Existing retail pharmacies and apps do not combine prescription refills, essential health product shopping, and private delivery tracking in one HIPAA-compliant experience. Sensitive prescriptions often lack discreet, private handling at retail counters, and patients must juggle multiple apps and phone calls to manage care.
Founded for a 2026 U.S. launch, we are a full-service mobile pharmacy in a major metropolitan area delivering prescriptions and health products on demand via a proprietary, HIPAA-compliant app. We offer a lean fixed-cost structure and scalable variable-cost model as a discreet, convenient alternative to traditional retail pharmacy visits.
Â
Solution
We provide a secure, HIPAA-compliant mobile platform that delivers prescriptions and curated health products to customers' doors the same day, solving time, mobility, privacy, and adherence gaps in traditional pharmacy care. One line: same-day delivered prescriptions plus live pharmacist care in a private, mobile workflow.
The app lets patients upload prescriptions for photo verification, schedule automated refills and dispatches, and connect with a licensed pharmacist via in-app messaging or video for counseling and medication reconciliation. It combines a streamlined recurring-med checkout with a curated OTC and wellness catalog to help elderly patients, busy professionals, parents, and caregivers manage medications without pharmacy visits or public exposure.
Â
Mission Statement
We exist to revolutionize the pharmacy experience by delivering unmatched convenience, privacy, and professional support through secure, clinical-grade technology. We make medication management effortless for seniors, caregivers, and busy families, improve health outcomes by ensuring fast, easy access to essential healthcare products, and uphold the highest standards of security and clinical excellence in every delivery to become the most trusted digital health partner in the communities we serve.
Â
Key Success Factors
Critical operational and financial milestones that must be met to achieve sustainable profitability and compliance.
-
Achieve 60% repeat customer rate by 2030 to sustain lifetime value.
-
Reduce CAC from $100 to $40 via optimized digital marketing and referrals.
-
Reach breakeven in 26 months (Feb 2028) through disciplined expense control.
-
Maintain 100% HIPAA compliance and secure state pharmacy licenses for lawful operation.
-
Increase average units per order to 2.0 to maximize revenue per delivery.
Financial Summary
Financial snapshot for the Executive Summary: five-year scale to EBITDA of $18,865,000 by 2030 with breakeven in Feb-2028.
Â
Ratio |
2026 |
2027 |
2028 |
Projected Revenue |
N/A |
N/A |
N/A |
Projected EBITDA |
-$684,000 |
-$456,000 |
$1,467,000 |
Expected ROI |
N/A |
N/A |
ROE 26.93; IRR 0.06 |
Â
Financial requirements include covering planned losses in 2026–2027, a minimum cash shortfall of $629,000 (Jan-2028), and capex and marketing investments; anticipated payback is 39 months with breakeven in Feb-2028 and long-term EBITDA of $18,865,000 by 2030.
Overall outlook: disciplined scale-up to positive cash flow and strong ROE by exit year.
Â
Funding Requirements
The plan requires $2,386,000 to cover 2026 CAPEX and scale-up losses while reaching breakeven in Feb-2028, with projected five-year EBITDA of $18,865,000, planned losses of $684,000 (2026) and $456,000 (2027), a 39-month payback, ROE 26.93, investor IRR 6%, and revenue split: prescriptions 55–65%, OTC health 20–25%, personal care 10–15%.
Â
Categories |
Amount, USD |
 |
 |
Product Development (App, infra, licenses) |
$220,000 |
CAPEX — Equipment, vehicles, inventory |
$160,000 |
Marketing (2026 annual budget) |
$50,000 |
Staffing (2026 salaries, all positions) |
$505,000 |
Operations (2026 fixed expenses annual) |
$138,000 |
Year‑one EBITDA shortfall |
$684,000 |
Working capital (minimum cash trough) |
$629,000 |
Total funding required |
$2,386,000 |
Â